Correction to: npj Imaging https://doi.org/10.1038/s44303-025-00079-x, published online 24 April 2025
In this article the ‘Conflict of Interest’ statement was incorrectly given as ‘The authors declare no competing interests’ but should have been ‘E.M.G holds equity and receives consulting income from Reveal Pharmaceuticals, a company that is developing manganese-based MRI contrast agents’. The original article has been corrected”.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Mani, V., Chu, W.T., Yang, HJ. et al. Author Correction: Reactive oxygen species-related oxidative changes are associated with splenic lymphocyte depletion in Ebola virus infection. npj Imaging 3, 24 (2025). https://doi.org/10.1038/s44303-025-00091-1
Published:
Version of record:
DOI: https://doi.org/10.1038/s44303-025-00091-1
